Alex Gorsky formally became Johnson & Johnson’s CEO today, amid ongoing trouble with product recalls, manufacturing problems and government inquiries. Mr. Gorsky plans to rethink how the company develops new drugs and raise the bar on innovation, according to the report.
More Articles on Orthopedic Devices:
AlloSource Hires Dale Binke as Vice President of Marketing & Sales
Orthofix Sells Sports Medicine Business for $157.5M
Johnson & Johnson Q1 Orthopedic Sales Flat
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
